The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeeing Machines Regulatory News (SEE)

Share Price Information for Seeing Machines (SEE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 5.05
Bid: 5.02
Ask: 5.09
Change: 0.295 (6.20%)
Spread: 0.07 (1.394%)
Open: 4.875
High: 5.05
Low: 4.70
Prev. Close: 4.755
SEE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Joint Venture created

15 Oct 2014 07:00

RNS Number : 2667U
Seeing Machines Limited
15 October 2014
 



Seeing Machines and Australian National University Sign Truefield Joint Venture

New entity created to commercialise ophthalmic-research IP

 

15 October 2014

 

Seeing Machines Limited (AIM: SEE), the AIM listed technology company with a focus on operator monitoring and intervention sensing technologies and services, is proud to announce the formation of a new joint venture, NuCoria Pty. Ltd., with The Australian National University (ANU) to commercialise TrueField Analyzer (TFA) Intellectual Property. Leveraging Seeing Machines' patented IP, technical expertise, and ANU's technology transfer & commercialisation successes, NuCoria will be dedicated to bringing revolutionary medical devices to market.

The TrueField Analyzer was originally developed collaboratively between ANU and Seeing Machines, and each of them has licensed their relevant existing intellectual property to NuCoria. NuCoria is a strategic arrangement that allows Seeing Machines to focus on core opportunities and competencies, including its alliances with Caterpillar Global Mining and TK Holdings (part of the Takata Group) and other rapidly emerging transport sector opportunities. ANU, following its own successful sale of Lithicon for A$76m, will take the lead in managing, staffing, and funding NuCoria. Seeing Machines will have an initial interest of 18% of NuCoria, will nominate a non-executive director and will receive royalties from any future licensing deals the new Company enters into.

NuCoria will become the primary vehicle for emerging ophthalmic-technology IP from ANU research centres. Professor Ted Maddess, TFA inventor and Director of the ARC Centre of Excellence in Vision Science, said: "We have been working with Seeing Machines to produce a rapid non-contact objective way of mapping the visual fields of both eyes at the same time. We have now published 17 studies showing that the new method has utility for the top three blinding diseases: glaucoma, macular degeneration and diabetic retinopathy, and also for some neurological disorders. The method continues to evolve and improve."

Ken Kroeger, CEO of Seeing Machines, said: "This is a fantastic outcome for all parties. Our company's DNA & legacy is closely tied with the ANU, hence I firmly believe that they are the right partners to move forward with this exciting technology. While the core focus of Seeing Machines is to save lives with our Driver Safety System (DSS) in the mining and road-transport industries, being able to work with strategic partners in exciting applications of our core-technology is part-and-parcel of how we operate."

Michael Cardew-Hall, ANU Pro-Vice Chancellor of Innovation and Advancement, said: "This is an exciting development in commercialisation of the TrueField Analyzer technology. The ANU has been committed to partnering with Seeing Machines in the development of the TrueField IP which was originally generated from research at the University. We believe that it has the potential to have significant benefits in the area of ophthalmology. The links between ANU and Seeing Machines are long standing, with it originally being a start up from the University itself. The NuCoria collaboration brings the expertise of Seeing Machines and ANU together to take this technology to market."

_______________________________________

 

Enquiries:

Seeing Machines Limited

www.seeingmachines.com

Ken Kroeger, Managing Director and CEO

+61 2 6103 4700

Ken.Kroeger@seeingmachines.com

James Walker, Finance Director

+61 2 6103 4700

James.Walker@seeingmachines.com

finnCap Ltd, Broker for Seeing Machines

Ed Frisby / Ben ThompsonCorporate Finance

+44 20 7220 0500

Victoria BatesCorporate Broking

Newgate Threadneedle, Investment Communications for Seeing Machines

Robyn McConnachie

 

 

Josh Royston

Tel: +44 20 7653 9852

Mob: +44 7540 706 191

r.mcconnachie@newgatethreadneedle.com

Tel: +44 20 7653 9844

Mob: +44 7789 003 223

j.royston@newgatethreadneedle.com

About Seeing Machines

Seeing Machines, (AIM: SEE), is an AIM-listed technology company that specialises in operator monitoring and intervention technologies and services. Its software and engineering services are used in products and applications that range from devices that improve driver safety and save lives to assessing trainees in simulators and simplifying the relationships between people and technology. Seeing Machines technology is used worldwide across the automotive, mining, transport and aviation industries; as well as many of the leading academic research groups and transportation authorities. Seeing Machines is headquartered in Australia, and has offices in Tucson, Arizona and Mountain View, California. The Company counts Caterpillar, Takata and Eye Tracking Inc as its partners and BHP Billiton, Freeport McMoran, Teck, Toll Holdings amongst its customers.

 

About The Australian National University

The Australian National University was established in 1946 to support the development of national unity and identity, to improve Australia's understanding of itself and its neighbours, and to contribute to economic development and social cohesion. ANU is a celebrated place of intensive research, education and policy engagement - setting the standard on issues of national and international importance. Its body of students is drawn from across the nation and around the world. ANU is a global university that consistently ranks amongst the world's finest educational institutions, and is a centre of unparalleled intellectual talent and research excellence. The University's research has been involved in the creation of a number of successful spin-off companies, including Seeing Machines, Beta Therapeutics and Lithicon.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAMIBTTMBIBBTI
Date   Source Headline
2nd May 202410:30 amRNSDirector/PDMR Shareholding
1st May 20247:00 amRNSAutomotive Program Extension to 2032
26th Apr 202411:00 amRNSDirector/PDMR Shareholding
25th Mar 20248:06 amRNSDirector/PDMR Shareholding
18th Mar 20247:00 amRNSHalf year results and financial report
28th Feb 20247:00 amRNSNotice of Results
8th Feb 20247:00 amRNSH1 FY2024 Trading Update & Quarterly KPIs
10th Jan 20247:00 amRNSNew Orders for Guardian Generation 3
9th Jan 20247:00 amRNSSeeing Machines unveils latest Guardian technology
3rd Jan 20247:00 amRNSSeeing Machines to showcase technology at CES 2024
20th Dec 20237:00 amRNSSeeing Machines announces US$30M European OEM win
13th Dec 20238:02 amRNSSeeing Machines welcomes U.S. NHTSA announcement
12th Dec 20237:00 amRNSSeeing Machines Wins Prestigious Road Safety Award
29th Nov 20237:57 amRNSResult of AGM
24th Nov 20237:00 amRNSAGM – reminder and correction of login details
8th Nov 20237:00 amRNS16th Automotive program awarded & Q1 FY2024 KPIs
6th Nov 202311:26 amRNSDirector/PDMR Shareholding
31st Oct 202311:50 amRNSDirector/PDMR Shareholding
31st Oct 20237:00 amRNSNotice of AGM
27th Oct 20237:19 amRNSDirector/PDMR Shareholding
27th Oct 20237:13 amRNSDirector/PDMR Shareholding
25th Oct 20237:55 amRNSDirector/PDMR Shareholding
25th Oct 20237:00 amRNSBoard Changes
20th Oct 20239:30 amRNSDirector/PDMR Shareholding
20th Oct 20239:21 amRNSDirector/PDMR Shareholding
19th Oct 20238:47 amRNSDirector/PDMR Shareholding
18th Oct 202310:06 amRNSDirector/PDMR Shareholding
17th Oct 20239:41 amRNSDirector/PDMR Shareholding
16th Oct 20237:00 amRNSYear End Results – FY2023
16th Oct 20237:00 amRNSDevelopment of aviation fatigue detection solution
14th Sep 20237:00 amRNSNotice of Full Year Results 2023
7th Sep 20235:31 pmRNSDirector/PDMR Shareholding
22nd Aug 20237:00 amRNSFY2023 Trading Update & Q4 KPIs
18th Jul 20237:30 amRNSDirector/PDMR Shareholding
30th Jun 20237:00 amRNSDirector/PDMR Shareholding
30th Jun 20237:00 amRNSCEO Incentive Plan
28th Jun 20231:44 pmRNSDirector/PDMR Shareholding
28th Jun 20237:00 amRNSDirector/PDMR Shareholding
26th Jun 202311:38 amRNSDirector/PDMR Shareholding
23rd Jun 20238:55 amRNSDirector/PDMR Shareholding
20th Jun 20237:30 amRNSCollaboration with synthetic data specialist
19th Jun 20238:00 amRNSSeeing Machines to attend Stifel Tech Conference
25th May 20239:53 amRNSDirector/PDMR Shareholding
22nd May 20239:46 amRNSDirector/PDMR Shareholding
16th May 20237:00 amRNSExclusive Agreement Signed with Collins Aerospace
4th May 20237:00 amRNSKey Performance Indicators Q3 FY2023
17th Apr 20239:29 amRNSDirector/PDMR Shareholding
13th Apr 202312:36 pmRNSDirector/PDMR Shareholding
11th Apr 202311:15 amRNSPDMR Shareholding
6th Apr 20232:45 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.